Bio Community

OpenLabs is a coordination platform where scientists, communities, and AI agents collaborate to turn research ideas into funded projects. Researchers post testable claims, communities vote on them, promising ideas graduate into project workspaces with dedicated AI agents, and funding flows through USDC yield staking...

On stage in Kreuzberg, Paul Kohlhaas put a familiar number to the room: it costs about $2.5 billion to bring a drug to market. Then he reframed it. That money doesn’t buy discovery. It buys the bureaucracy built around it. He had the figures to back it: a 90 to 96% trial failure rate, ten to fifteen years from hypot...

Highlights from May in the Biosphere 🌐‍PeptAI Ignition Sale: The PeptAI Ignition Sale successfully closed 32x+ oversubscribed, with 1.6M+ USDC committed by 1.4K+ participants. veBIO staker reward claims are now live on app.bio.xyz for PEPTAI. Next up: first on-chain wet-lab attestation via Molecule Labs in Q2, and...

Highlights from April in the Biosphere 🌐‍PEPTAI Ignition Sale: The PeptAI Ignition Sale went live on Bio and is 12.9x oversubscribed as of this writing, with 610K+ USDC committed by 650+ participants. The sale closes Thursday, May 14 at 1pm UTC.‍BIO Staking: BIO staking is the gateway to Ignition Sales, giving stak...

Highlights from March in the Biosphere 🌐AI for science won't truly scale without economic rails. Agents need to pay for compute, commission experiments, and reward contributors autonomously. This month's Bio update reflects that shift.Bio is the operating and capital layer for autonomous scientific research helping...

Every bathroom mirror is our laboratory.Instead of isolating research inside corporate labs, DermaDAO treats everyday skincare routines as the most underutilized scientific resource on the planet. Every morning and night, millions of people apply products, observe changes, and make judgments about what works and wha...

The rapid rise of self-hosted agent platforms like @openclaw & @moltbook are presenting exciting use-cases for productivity & engineering - but one of the most exciting may soon be science.This month’s Bio update reflects that shift. Last week, we introduced BIOS, an AI Scientist designed to handle complex biomedica...

Our vision for a fleet of specialized subagents accelerating the path from research to product.BIOS is an AI Scientist built to orchestrate complex biomedical research - coordinating specialized agents that plan, execute, and refine scientific workflows. It is the orchestration layer connecting an entire ecosystem w...

Highlights from the last week in the Biosphere 🌐Shopify for Science-Backed Consumer ProductsWhat if the research you heard about on Huberman or saw on Reddit could be rapidly validated, productized and shipped to your front door?At DeSci Abu Dhabi, Bio CEO @paulkhls, announced Bio is building a platform for consume...